Share on StockTwits

Gentiva Health Services (NASDAQ:GTIV)’s share price hit a new 52-week high during trading on Friday , Analyst Ratings Net reports. The stock traded as high as $18.69 and last traded at $18.60, with a volume of 90,063 shares trading hands. The stock had previously closed at $18.41.

A number of analysts have recently weighed in on GTIV shares. Analysts at Zacks reiterated an “outperform” rating on shares of Gentiva Health Services in a research note on Wednesday, August 6th. They now have a $22.00 price target on the stock. Separately, analysts at Credit Suisse reiterated an “underperform” rating on shares of Gentiva Health Services in a research note on Wednesday, August 6th. They now have a $18.00 price target on the stock, up previously from $14.00. Finally, analysts at Piper Jaffray raised their price target on shares of Gentiva Health Services from $14.00 to $17.25 in a research note on Wednesday, August 6th. One analyst has rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average price target of $17.42.

The stock’s 50-day moving average is $16.99 and its 200-day moving average is $12.2. The company’s market cap is $693.3 million.

Gentiva Health Services (NASDAQ:GTIV) last released its earnings data on Tuesday, August 5th. The company reported $0.27 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.23 by $0.04. The company had revenue of $498.00 million for the quarter, compared to the consensus estimate of $492.31 million. During the same quarter last year, the company posted $0.22 earnings per share. Gentiva Health Services’s revenue was up 20.2% compared to the same quarter last year. Analysts expect that Gentiva Health Services will post $1.07 EPS for the current fiscal year.

Gentiva Health Services, Inc (NASDAQ:GTIV) is engaged in providing home health services and hospice services.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.